CSIMarket
 


Penumbra Inc  (PEN)
Other Ticker:  
 

Penumbra Inc's Working Capital Ratio

PEN's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




PEN Working Capital Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Change 19.19 % 34.76 % 16.3 % 16.3 % 7.41 %
Y / Y Current Assets Change 8.33 % 9.93 % 8.69 % 10.32 % 13.18 %
Working Capital Ratio MRQ 5.23 4.93 5.31 5.53 5.76
Overall Ranking # # # # #
Seq. Current Liabilities Change -4.99 % 11.92 % 5.6 % 6.15 % 7.42 %
Seq. Current Assets Change 0.79 % 4 % 1.3 % 2.02 % 2.28 %



Working Capital Ratio third quarter 2022 Comment
Penumbra Inc's Current Assets grew by 0.79 % in the III. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Penumbra Inc's Working Capital Ratio to 5.23, above Penumbra Inc average Working Capital Ratio.

Within Medical Equipment & Supplies industry Penumbra Inc booked the highest Working Capital Ratio than Penumbra Inc in the third quarter 2022. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is PEN most successful ?
Working Capital Ratio PEN on the trailing twelve month basis
Working Capital Ratio third quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall Market #


Working Capital Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Penumbra Inc's Current Liabilities $ 138 Millions Visit PEN's Balance sheet
Penumbra Inc's Current Assets $ 724 Millions Visit PEN's Balance sheet
Source of PEN's Sales Visit PEN's Sales by Geography


Cumulative Penumbra Inc's Working Capital Ratio

PEN's Working Capital Ratio for the trailling 12 Months

PEN Working Capital Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities TTM Growth 19.19 % 34.76 % 16.3 % 16.3 % 7.41 %
Y / Y Current Assets TTM Growth 8.33 % 9.93 % 8.69 % 10.32 % 13.18 %
Working Capital Ratio TTM 5.24 5.36 5.64 5.74 5.82
Total Ranking TTM # 589 # 982 # 937 # 721 # 1002
Seq. Current Liabilities TTM Growth -4.99 % 11.92 % 5.6 % 6.15 % 7.42 %
Seq. Current Assets TTM Growth 0.79 % 4 % 1.3 % 2.02 % 2.28 %


TTM Working Capital Ratio Comment
On the trailing twelve months basis Due to decrease in Current Liabilities in the III. Quarter to $138.33 millions, average cumulative Working Capital Ratio decreased to 5.24 below the Penumbra Inc average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operatig within Medical Equipment & Supplies industry 53 other companies have achieved higher Working Capital Ratio than Penumbra Inc. While overall ranking remained unchanged compare to previous quarter at no. 589.

Explain Working Capital Ratio
Where is PEN most successful ?
Working Capital Ratio PEN on the trailing twelve month basis

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 54
Healthcare Sector # 382
Within the Market # 589


TTM Working Capital Ratio Statistics
High Average Low
8.5 6.42 5.24
(Jun 30 2017)   (Sep 30 2022)




Companies with similar Working Capital Ratio in the quarter ending Sep 30 2022, within Medical Equipment & Supplies Industry Working Capital RatioSep 30 2022 MRQ Current AssetsSep 30 2022 MRQ Current Liabilities
Isoray Inc   14.38 $ 57.540  Millions$ 4.001  Millions
Novocure Limited  14.31 $ 1,102.373  Millions$ 77.026  Millions
Utah Medical Products Inc  13.44 $ 84.242  Millions$ 6.269  Millions
Taitron Components Incorporated  12.97 $ 14.306  Millions$ 1.103  Millions
Iradimed Corporation  12.83 $ 71.873  Millions$ 5.604  Millions
Sight Sciences Inc   12.79 $ 222.343  Millions$ 17.386  Millions
Neurometrix Inc   12.79 $ 23.432  Millions$ 1.832  Millions
Vivos Inc  12.71 $ 2.046  Millions$ 0.161  Millions
Femasys Inc   12.48 $ 17.292  Millions$ 1.385  Millions
Akili Inc   12.27 $ 161.278  Millions$ 13.140  Millions
Transmedics Group Inc   12.11 $ 250.586  Millions$ 20.689  Millions
Neuropace Inc   11.96 $ 104.370  Millions$ 8.725  Millions
Hyperfine Inc   11.54 $ 143.716  Millions$ 12.459  Millions
Tenon Medical Inc   10.79 $ 13.665  Millions$ 1.266  Millions
Procept Biorobotics Corporation  10.56 $ 288.932  Millions$ 27.359  Millions
Asensus Surgical Inc   10.52 $ 103.530  Millions$ 9.844  Millions
Inspire Medical Systems inc   10.05 $ 495.544  Millions$ 49.291  Millions
Venus Concept Inc   10.01 $ 80.762  Millions$ 8.067  Millions
Abiomed Inc   9.83 $ 1,062.798  Millions$ 108.098  Millions
Aethlon Medical Inc   9.76 $ 20.504  Millions$ 2.101  Millions
Inari Medical Inc   9.70 $ 410.571  Millions$ 42.343  Millions
Vivani Medical Inc   9.69 $ 54.463  Millions$ 5.620  Millions
Avita Medical Inc   9.64 $ 91.720  Millions$ 9.513  Millions
Sonendo Inc   9.51 $ 127.031  Millions$ 13.363  Millions
Bluejay Diagnostics Inc   9.15 $ 13.936  Millions$ 1.523  Millions
Clearpoint Neuro Inc   8.83 $ 53.814  Millions$ 6.095  Millions
Assure Holdings Corp   8.68 $ 31.634  Millions$ 3.646  Millions
Rxsight Inc   8.50 $ 139.162  Millions$ 16.368  Millions
Pulmonx Corporation  8.44 $ 183.111  Millions$ 21.686  Millions
Lyra Therapeutics Inc   8.25 $ 112.230  Millions$ 13.605  Millions

Date modified: 2022-11-06T02:28:20+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

WTMA's Profile

Stock Price

WTMA's Financials

Business Description

Fundamentals

Charts & Quotes

WTMA's News

Suppliers

WTMA's Competitors

Customers & Markets

Economic Indicators

WTMA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071